ARM 24.174.1412. ADDITIONS, DELETIONS, AND RESCHEDULING OF DANGEROUS DRUGS

(1) In addition to those dangerous drugs scheduled in 50-32-222, 50-32-224, 50-32-226, 50-32-229, and 50-32-232, MCA, the board adds the following to dangerous drug schedules after considering federal regulations and/or the criteria enumerated in Title 50, chapter 32, part 2, MCA: (a) Schedule I: (i) none at this time; (b) Schedule II: (i) none at this time; (c) Schedule III: (i) methasterone; (ii) perampanel; and (iii) prostanozol; (d) Schedule IV: (i) tramadol; (ii) alfaxalone; (iii) suvorexant; and (iv) lorcaserin; (e) Schedule V: (i) ezogabine. (2) The board deletes the following dangerous drugs from the schedules in 50-32-222, 50-32-224, 50-32-226, 50-32-229, and 50-32-232, MCA, after considering federal regulations and/or the criteria enumerated in Title 50, chapter 32, part 2, MCA: (a) Schedule I: (i) none at this time; (b) Schedule II: (i) naloxegol; (c) Schedule III: (i) 50-32-226(4)(c) and (d), MCA (hydrocodone combination products); (d) Schedule IV: (i) none at this time; (e) Schedule V: (i) none at this time. (3) After considering federal regulations and/or the criteria enumerated in Title 50, chapter 32, part 2, MCA, the board reschedules the following dangerous drugs from those scheduled in 50-32-222, 50-32-224, 50-32-226, 50-32-229, and 50-32-232, MCA: (a) Schedule I: (i) none at this time; (b) Schedule II: (i) none at this time; (c) Schedule III: (i) none at this time; (d) Schedule IV: (i) modafinil; (e) Schedule V: (i) none at this time.